Your search returned 15 studies. (Get alerts for new studies):
- Mismatched Donor Lymphocyte Infusions for Relapsed Disease Following Allogeneic Stem Cell Transplantation
Conditions: Leukemia, Myeloid, Acute - Leukemia, Lymphoblastic, Acute - Leukemia, Myelocytic, Chronic
1 Location available
- Acute Promyelocytic Leukemia (APL) Treated With ATRA, Arsenic Trioxide and Gemtuzumab Ozogamicin
Conditions: Leukemia
1 Location available
- Evaluation of a New Anti-cancer Immunotherapy in Adult Acute Myeloid Leukemia Patients With a Suboptimal Clinical Response to Induction Chemotherapy
Conditions: WT1-positive Acute Myeloid Leukemia - Leukaemia, Myelocytic, Acute
2 Locations available
- Combined Tretinoin and Arsenic Trioxide for Patients With Newly Diagnosed Acute Promyelocytic Leukemia Followed by Risk-Adapted Postremission Therapy
Conditions: Acute Promyelocytic Leukemia
1 Location available
- Safety, Efficacy, & Pharmacokinetic Study of Tamibarotene to Treat Patients With Relapsed or Refractory APL
Conditions: Acute Promyelocytic Leukemia
2 Locations available
- Phase I Study of ON 01910.Na in Refractory Leukemia or Myelodysplastic Syndrome (MDS)
Conditions: Acute Myelocytic Leukemia - Acute Lymphocytic Leukemia - Chronic Myelocytic Leukemia - Chronic Lymphocytic Leukemia - Myelodysplastic Syndromes
1 Location available
- TXA127 in Enhancement of Engraftment in Adult Double Cord Blood Transplantation
Conditions: Double Cord Blood Transplant - Acute Myelogenous Leukemia - Myelodysplastic Syndrome - Myelofibrosis - Acute Lymphoblastic Leukemia - Chronic Myelocytic Leukemia - Non Hodgkins Lymphoma - Hodgkins Lymphoma - Chronic Lymphocytic Leukemia
1 Location available
- Hematopoietic Stem Cell Transplantation (HSCT) Using CD34 Selected Mismatched Related Donor and One Umbilical Cord Unit
Conditions: Leukemia, Lymphocytic, Acute - Leukemia, Lymphocytic, Chronic - Leukemia, Myelocytic, Acute - Leukemia, Myeloid, Chronic - Lymphoma, Non-Hodgkin - Lymphoma, Hodgkins
1 Location available
- Reduced Intensity Conditioning Versus Myeloablative Conditioning for Acute Myeloid Leukemia or Myelodysplastic Syndrome (BMT CTN 0901)
Conditions: Leukemia, Myelocytic, Acute
28 Locations available
- Gemtuzumab and Combination Chemotherapy in Treating Patients With Previously Untreated Acute Promyelocytic Leukemia
Conditions: Leukemia
176 Locations available
- Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Acute Promyelocytic Leukemia
Conditions: Leukemia
101 Locations available
- Safety and Efficacy of 72-hour and 120-hour Infusion of ON 01910.Na in Acute Myeloid Leukemia (AML) and Acute Lymphoid Leukemia (ALL)
Conditions: Acute Myeloid Leukemia - Acute Myelocytic Leukemia - Acute Lymphoid Leukemia - Acute Lymphocytic Leukemia
1 Location available
- Accuracy Testing of the Chromosomal Aberration and Gene Mutation Markers of the AMLProfiler
Conditions: Acute Myeloid Leukemia (AML) - Acute Promyelocytic Leukemia (APL) - Refractory Anemia With Excess of Blasts (RAEB)
2 Locations available
- Pilot Lenalidomide in Adult Diamond-Blackfan Anemia Patients w/ RBC Transfusion-Dependent Anemia
Conditions: Anemia - Leukemia - Leukemia, Myelocytic, Acute - Dysmyelopoietic Syndromes
1 Location available
- Diagnostic Study of Patients With Acute Lymphoblastic Leukemia or Acute Promyelocytic Leukemia
Conditions: Leukemia
55 Locations available
|